Latest California Healthline Stories
KHN Files Lawsuit To Force Feds To Disclose Medicare Advantage Audits
The Freedom of Information Act lawsuit could spur the Centers for Medicare & Medicaid Services to release audits that document up to $650 million in overcharges.
States Target Vaping With Bans. In California, The Action Is Local.
Several states have adopted bans on vaping products, but California isn’t going that far. Instead, cities and counties in the Golden State are stepping in to prohibit the sale of flavored tobacco products within their jurisdictions — or ban the sale of e-cigarettes altogether.
Uber And Lyft Ride-Sharing Services Hitch Onto Medicaid
Ride-sharing companies promise better service for enrollees and lower costs for states. But the services are not for everyone on Medicaid.
The Delicate Issue Of Taking Away A Senior’s Smartphone
Knowing when — and how — to limit a loved one’s access to digital devices is akin to taking their car keys.
Insurers Test New Way To Cut Maternity Care Costs: Bundling
More insurers are experimenting with paying health care providers one lump sum to cover the cost of maternity care. Physicians and insurers hope the model — known as bundled payments — will help improve health outcomes.
In Tiny Doses, An Addiction Medication Moonlights As Treatment For Chronic Pain
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain — when prescribed in low doses. But few doctors or patients seem to know about it.
As Health Care Costs Rise, Workers At Low-Wage Firms May Pay A Larger Share
People at companies with large numbers of people earning $25,000 or less faced bigger deductibles for single coverage and were asked to pony up a larger share of their income in premiums than those at other firms.
5 Takeaways From Court Arguments On Trump’s New Abortion Referral Rule
The legal fight over the Trump administration’s new rule barring health clinics that receive federal family planning grants from referring women for abortion services played out before a divided federal appeals court Monday. Here are key takeaways.
As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients’ Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.
Hill Hodgepodge: Pelosi Draws From Democrats, GOP And Trump For Drug Plan
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.